Login to Your Account



Chiron's Pulminiq Receives Mixed Vote From FDA Panel

By Aaron Lorenzo


Tuesday, June 7, 2005
ROCKVILLE, Md. - In baseball, a tie goes to the runner, but biotech isn't baseball and nothing definitive came out of Monday's FDA advisory committee meeting on Chiron Corp.'s Pulminiq (cyclosporine). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription